Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05586399
Other study ID # NA -COPD
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 15, 2022
Est. completion date June 30, 2024

Study information

Verified date September 2022
Source Molde University College
Contact Norun Aagård, Msc
Phone + 99364951
Email norun.aagaard@treningsklinikken.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect on maximal strength training on muscle function, lung function and quality of life for patients diagnosed with COPD grade II-III (Gold scale). Each patient will complete a total of 20 exercise session participating in a rehabilitation program for 4 weeks. Physiological and functional testing will be performed 4 weeks before the training intervention, at baseline and after the intervention period.


Description:

COPD is a group of diseases which affect the pulmonary system and leads to airflow restrictions and breathing difficulty. Other healthcare related problems, such as chronic inflammation, reduced muscle function, anxiety, depression and cardiovascular diseases are often seen in patients who are diagnosed with COPD. Frequent participation in physical activity has been shown to improve the general public health, and serve as a prevention for development of various chronic diseases. Physical activity has at the same time been shown to be effective in treatment of both pulmonary and cardiovascular diseases. It also has the potential to reduce the need for health services, and can replace or reduce the need for medicinal treatments. In this study we are want to investigate the effect of maximal strength training in COPD patients grade II-III on both muscle function and lung function. Maximal strength training (MST) have previously been shown as a superior intervention to achieve increased 1RM and fast development of power, also known as rate of force development (RFD). Lung function in COPD patients has been shown in previous research to be improved following maximal strength training. The participants will partake in a total of 20 MST interventions during a rehabilitation period of 4 weeks. The sessions will be distributed five times a week located in two different Rehabilitation Centers in Trondheim, Norway. The strength training will be performed in groups, supervised by one or more coworkers in the project. MST will be performed with 4 series of 4 RM in a horizontal leg press machine, supervised by a coworker in the project. As part of the rehabilitation program, participants will also perform endurance training parallell to the MST sessions. The participants will function as their own control group in the project. They will participate in a pre-test 4 weeks before the intervention period. After the pre-test they will be instructed to live as usual for the next 4 weeks. They will then start the intervention period, with tests performed at start and end of the period. Both subjective and objective measurements will be performed 4 weeks before, at baseline and after the intervention period. All physiological tests will be completed during the same day. A standardized work economy test on a treadmill will be used in assessment of endurance capacity, with an expected duration of 4 minutes. The work economy test will be followed by a standardized graded test of maximal oxygen consumption, with a maximal duration of 10 minutes. Both endurance tests will be performed on a treadmill, with continuous heart rate monitoring. Approximately 5-10 minutes after finishing the endurance tests, a test of maximal dynamic strength will be performed (1RM test). The test will be performed in a horizontal leg press machine. After three submaximal warm-up sets, the load will be gradually increased until the participant fails to perform the test. Duration of rest periods between sets will be standardized to 3 minutes. Rate of force development will also be assessed, with the use of a force plate in the same horizontal leg press machine. There will also be performed functional tests (6 minute walk test, Timed Up and Go and stair climb test). All participants will also answer standardized questionnaires regarding health related quality of life.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - COPD-diagnosis grade II-III (Gold Classification) - Patients in one of two rehabilitation centres in Trondheim, Norway. - Must be able to perform the test procedures walking or running on a treadmill. - Must participate in at least 18 of the 20 planned training sessions. Exclusion Criteria: - Other pulmonary disease than COPD - Diabetes mellitus or other metabolic diseases - Use of corticosteroids the last 6 weeks - Pulmonary infection the last 4 weeks

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Maximal strength training in COPD
Participate in a rehabilitation program for 4 weeks, with exercise 5 times a week. Supervised maximal strength training in a leg press machine for a total of 20 exercise sessions. Patients will participate in rehabilitation in one of two rehabilitations centers in Trondheim, Norway.

Locations

Country Name City State
Norway My Workout - Medical Rehabilitation Clinic Trondheim

Sponsors (1)

Lead Sponsor Collaborator
Molde University College

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Maximal Strenght Measured in 1 repetition maximum (kg) in leg press. 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Rate of Force Development Measured in Newton using a force plate 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Forced Expiratory Volume (FEV1) Measured using spirometry as the maximal volume of air (liter) exhaled in the first second of expiration 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Peak Expiratory Flow (PEF) Measured using spirometry as the maximal speed of expiration (Measured as liter/min) 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Work Economy Measured using CPET walking on a treadmill at a standardized speed and incline (Measured as VO2 ml/kg/min) 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Maximal Oxygen Consumption Measured using CPET in maximal test walking until exhaustion(Measured as VO2 ml/kg/min) 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Stair Climbing-test Measured in seconds as the average of two attempts 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in Timed up and Go-test Measured in seconds as the average of two attempts 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Primary Change in 6 Minutes Walk Test Measured in meters 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Secondary Changes in health-related quality of life - Norwegian RAND36 Questionnaire scoring on a 0-100 scale with higher scores identifying better outcomes 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Secondary Changes in health-related quality of life - Hospital and Anxiety Score (HADS) Questionnaires - Change in total score from 0-21 where higher score may indicate anxiety and/or depression 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Secondary Changes in health-related quality of life - International physical activity questionnaire (IPAQ) Questionnaires - Change in MET-minutes of physical acitivity a week with higher score identifying better outcomes 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Secondary Changes in health-related quality of life - EQ-5D-5L Questionnaires - Change in health state from level 1-5 with lower level identifying better outcomes 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
Secondary Changes in health-related quality of life - Visual Analogue Scale (VAS) Questionnaires - Units on a Scale from 0-10 cm with lower score identifying better outcomes 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy